Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:tetrapeptide
go back to main search page
Accession:CHEBI:48030 term browser browse the term
Definition:Any molecule that contains four amino-acid residues connected by peptide linkages.
Synonyms:related_synonym: tetrapeptides
 alt_id: CHEBI:26931;   CHEBI:9500
 xref: KEGG:C01960


show annotations for term's descendants           Sort by:
carfilzomib term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Afp alpha-fetoprotein multiple interactions EXP carfilzomib inhibits the reaction [Diethylnitrosamine results in increased expression of AFP protein] CTD PMID:24632418 NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480 		JBrowse link
G Ar androgen receptor multiple interactions ISO carfilzomib inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:30818834 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Brca1 BRCA1, DNA repair associated increases response to substance ISO BRCA1 mutant form results in increased susceptibility to carfilzomib CTD PMID:25522274 NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304 		JBrowse link
G Brd4 bromodomain containing 4 multiple interactions ISO carfilzomib inhibits the reaction [ARV-825 results in increased degradation of BRD4 protein] CTD PMID:26051217 NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539 		JBrowse link
G Bsg basigin multiple interactions
decreases expression		 ISO carfilzomib promotes the reaction [[Dronabinol co-treated with Cannabidiol] results in decreased expression of BSG mRNA]
carfilzomib results in decreased expression of BSG mRNA		 CTD PMID:27769052 NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387 		JBrowse link
G Casp3 caspase 3 increases cleavage
increases activity
multiple interactions		 ISO
EXP		 carfilzomib results in increased cleavage of CASP3 protein
carfilzomib results in increased activity of CASP3 protein
apremilast inhibits the reaction [carfilzomib results in increased activity of CASP3 protein]		 CTD PMID:27769052 PMID:27785949 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Cat catalase decreases activity EXP carfilzomib results in decreased activity of CAT protein CTD PMID:27785949 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Ckm creatine kinase, M-type increases secretion
multiple interactions		 EXP
ISO		 carfilzomib results in increased secretion of CKM protein
apremilast inhibits the reaction [carfilzomib results in increased secretion of CKM protein]
Dexrazoxane inhibits the reaction [carfilzomib results in increased secretion of CKM protein]		 CTD PMID:26899300 PMID:27785949 NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720 		JBrowse link
G Cox8a cytochrome c oxidase subunit 8A decreases expression ISO carfilzomib results in decreased expression of COX8A mRNA CTD PMID:30818834 NCBI chr 1:204,402,118...204,404,439 JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression
multiple interactions		 ISO carfilzomib results in decreased expression of CXCR4 mRNA
carfilzomib promotes the reaction [[Dronabinol co-treated with Cannabidiol] results in decreased expression of CXCR4 mRNA]		 CTD PMID:27769052 NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO carfilzomib inhibits the reaction [Estradiol results in increased activity of ESR1 protein] CTD PMID:30818834 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO carfilzomib inhibits the reaction [Estradiol results in increased activity of ESR2 protein] CTD PMID:30818834 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919 		JBrowse link
G Esrra estrogen related receptor, alpha multiple interactions ISO carfilzomib inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]; carfilzomib inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases secretion
multiple interactions		 EXP carfilzomib results in increased secretion of GOT1 protein
apremilast inhibits the reaction [carfilzomib results in increased secretion of GOT1 protein]		 CTD PMID:27785949 NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO carfilzomib inhibits the reaction [Acetaminophen results in increased activity of GPT protein] CTD PMID:27900802 NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
G Ldha lactate dehydrogenase A multiple interactions
increases secretion		 EXP
ISO		 apremilast inhibits the reaction [carfilzomib results in increased secretion of LDHA protein]
Dexrazoxane inhibits the reaction [carfilzomib results in increased secretion of LDHA protein]		 CTD PMID:26899300 PMID:27785949 NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases expression
multiple interactions		 EXP carfilzomib results in increased expression of MAPK1 mRNA
apremilast inhibits the reaction [carfilzomib results in increased expression of MAPK1 mRNA]		 CTD PMID:27785949 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases expression
multiple interactions		 EXP carfilzomib results in increased expression of MAPK8 mRNA
apremilast inhibits the reaction [carfilzomib results in increased expression of MAPK8 mRNA]		 CTD PMID:27785949 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions EXP carfilzomib inhibits the reaction [Diethylnitrosamine results in increased expression of MMP2 protein] CTD PMID:24632418 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870 		JBrowse link
G Myh6 myosin heavy chain 6 multiple interactions
decreases expression		 ISO Dexrazoxane inhibits the reaction [carfilzomib results in decreased expression of MYH6 mRNA] CTD PMID:26899300 NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720 		JBrowse link
G Myh7 myosin heavy chain 7 increases expression
multiple interactions		 ISO carfilzomib results in increased expression of MYH7 mRNA
Dexrazoxane inhibits the reaction [carfilzomib results in increased expression of MYH7 mRNA]		 CTD PMID:26899300 NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases activity ISO carfilzomib results in increased activity of NFE2L2 protein CTD PMID:30818834 NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
decreases expression		 EXP apremilast inhibits the reaction [carfilzomib results in decreased expression of NFKBIA protein] CTD PMID:27785949 NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO carfilzomib inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA] CTD PMID:27900802 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Pgr progesterone receptor multiple interactions ISO carfilzomib inhibits the reaction [Promegestone results in increased activity of PGR protein] CTD PMID:30818834 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions ISO carfilzomib inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein] CTD PMID:30818834 NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656 		JBrowse link
G Prkcsh PRKCSH beta subunit of glucosidase II increases response to substance ISO PRKCSH gene mutant form results in increased susceptibility to carfilzomib CTD PMID:21685914 NCBI chr 8:20,534,787...20,546,493
Ensembl chr 8:20,534,880...20,546,492 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO carfilzomib inhibits the reaction [Acetaminophen results in increased expression of PTGS2 mRNA] CTD PMID:27900802 NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases expression
multiple interactions		 EXP carfilzomib results in increased expression of RELA mRNA
apremilast inhibits the reaction [carfilzomib results in increased expression of RELA mRNA]		 CTD PMID:27785949 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 decreases activity ISO carfilzomib results in decreased activity of TGFB1 protein CTD PMID:31652400 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions EXP carfilzomib inhibits the reaction [Diethylnitrosamine results in increased expression of TIMP1 protein] CTD PMID:24632418 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:1,212,972...1,217,664 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO carfilzomib inhibits the reaction [Acetaminophen results in increased expression of TNF protein] CTD PMID:27900802 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tp53 tumor protein p53 increases activity
affects activity		 ISO carfilzomib results in increased activity of TP53 protein
carfilzomib affects the activity of TP53 protein		 CTD PMID:30818834 PMID:35435491 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Zfand2a zinc finger AN1-type containing 2A increases expression ISO carfilzomib results in increased expression of ZFAND2A protein CTD PMID:31540997 NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677 		JBrowse link
gamma-glutamyl-glutathione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gsta4 glutathione S-transferase alpha 4 multiple interactions EXP GSTA4 protein binds to and affects the metabolism of gamma-glutamyl-glutathione CTD PMID:2619714 NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions EXP GSTP1 protein binds to and affects the metabolism of gamma-glutamyl-glutathione CTD PMID:2619714 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
goralatide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace angiotensin I converting enzyme increases expression
decreases expression
multiple interactions		 ISO goralatide results in increased expression of ACE mRNA
goralatide results in decreased expression of ACE mRNA
[BDKRB1 protein affects the activity of ACE protein] which affects the hydrolysis of goralatide; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of ACE mRNA]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of ACE protein]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in decreased expression of ACE2 mRNA]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in decreased expression of CDH1 protein]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of ACE mRNA]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of ACE protein]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of COL3A1 protein]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of VIM protein]]; goralatide affects the reaction [ACE2 protein affects the reaction [Silicon Dioxide results in increased expression of ACE mRNA]]; goralatide inhibits the reaction [AGT protein results in increased expression of ACE mRNA]; goralatide inhibits the reaction [AGT protein results in increased expression of ACE protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of ACE mRNA]		 CTD PMID:20096676 PMID:33007385 NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131 		JBrowse link
G Ace2 angiotensin converting enzyme 2 multiple interactions ISO ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of ACE2 mRNA]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of ACE2 protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of CDH1 protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of MAS1 protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of ACE mRNA]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of ACE protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of AGT protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in decreased expression of ACE2 mRNA]]; goralatide affects the reaction [ACE2 protein affects the reaction [AGT protein results in decreased abundance of angiotensin I (1-7)]]; goralatide affects the reaction [ACE2 protein affects the reaction [Silicon Dioxide results in decreased expression of ACE2 mRNA]]; goralatide affects the reaction [ACE2 protein affects the reaction [Silicon Dioxide results in decreased expression of ACE2 protein]]; goralatide affects the reaction [ACE2 protein affects the reaction [Silicon Dioxide results in increased expression of ACE mRNA]]; goralatide affects the reaction [ACE2 protein affects the reaction [Silicon Dioxide results in increased expression of AGT protein]]; goralatide inhibits the reaction [AGT protein results in decreased expression of ACE2 mRNA]; goralatide inhibits the reaction [AGT protein results in decreased expression of ACE2 protein]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of ACE2 mRNA]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of ACE2 protein] CTD PMID:33007385 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:30,293,589...30,340,977 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions ISO
EXP		 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of ACTA2 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of ACTA2 protein]
[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]
goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]]; goralatide inhibits the reaction [AGT protein results in increased expression of ACTA2 protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]		 CTD PMID:31181250 PMID:33007385 NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554 		JBrowse link
G Agt angiotensinogen multiple interactions ISO ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of ACE2 mRNA]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of ACE2 protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of CDH1 protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of MAS1 protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of ACE mRNA]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of ACE protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of AGT protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]]; ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]]; goralatide affects the reaction [ACE2 protein affects the reaction [AGT protein results in decreased abundance of angiotensin I (1-7)]]; goralatide affects the reaction [ACE2 protein affects the reaction [Silicon Dioxide results in increased expression of AGT protein]]; goralatide inhibits the reaction [AGT protein results in decreased abundance of angiotensin I (1-7)]; goralatide inhibits the reaction [AGT protein results in decreased expression of ACE2 mRNA]; goralatide inhibits the reaction [AGT protein results in decreased expression of ACE2 protein]; goralatide inhibits the reaction [AGT protein results in decreased expression of CDH1 protein]; goralatide inhibits the reaction [AGT protein results in decreased expression of MAS1 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of ACE mRNA]; goralatide inhibits the reaction [AGT protein results in increased expression of ACE protein]; goralatide inhibits the reaction [AGT protein results in increased expression of ACTA2 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of AGT protein]; goralatide inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]; goralatide inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of VIM protein]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of AGT protein alternative form]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of AGT protein]
[goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]; [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of PTCH1 protein]; [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of ACTA2 protein]; [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of GLI1 protein]; [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of GLI2 protein]; [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of SHH protein]; [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of SMO protein]; goralatide inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]; goralatide inhibits the reaction [AGT protein results in decreased expression of PTCH1 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of ACTA2 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of GLI1 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of GLI2 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of SHH protein]; goralatide inhibits the reaction [AGT protein results in increased expression of SMO protein]		 CTD PMID:31181250 PMID:33007385 NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions ISO ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]]; goralatide inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of AGTR1 protein] CTD PMID:33007385 NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946 		JBrowse link
G Bdkrb1 bradykinin receptor B1 affects abundance
multiple interactions		 ISO BDKRB1 protein affects the abundance of goralatide
[BDKRB1 protein affects the activity of ACE protein] which affects the hydrolysis of goralatide		 CTD PMID:20096676 NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of CDH1 protein]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in decreased expression of CDH1 protein]]; goralatide inhibits the reaction [AGT protein results in decreased expression of CDH1 protein]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of CDH1 protein] CTD PMID:33007385 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775 		JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions ISO ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]]; goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of COL3A1 protein]]; goralatide inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of COL3A1 protein] CTD PMID:33007385 NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547 		JBrowse link
G Gli1 GLI family zinc finger 1 multiple interactions ISO
EXP		 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of GLI1 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of GLI1 protein]
[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of GLI1 protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of GLI1 protein]		 CTD PMID:31181250 NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251 		JBrowse link
G Gli2 GLI family zinc finger 2 multiple interactions ISO
EXP		 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of GLI2 protein]; goralatide inhibits the reaction [AGT protein results in increased expression of GLI2 protein]
[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of GLI2 protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of GLI2 protein]		 CTD PMID:31181250 NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574 		JBrowse link
G Gli3 GLI family zinc finger 3 multiple interactions EXP
ISO		 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]
[goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]; goralatide inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]		 CTD PMID:31181250 NCBI chr17:49,438,567...49,709,712
Ensembl chr17:49,438,567...49,709,712 		JBrowse link
G Mas1 MAS1 proto-oncogene, G protein-coupled receptor multiple interactions ISO ACE2 protein affects the reaction [goralatide inhibits the reaction [AGT protein results in decreased expression of MAS1 protein]]; goralatide inhibits the reaction [AGT protein results in decreased expression of MAS1 protein]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of MAS1 protein] CTD PMID:33007385 NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709 		JBrowse link
G Ptch1 patched 1 multiple interactions EXP
ISO		 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of PTCH1 protein]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of PTCH1 protein]
[goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of PTCH1 protein]; goralatide inhibits the reaction [AGT protein results in decreased expression of PTCH1 protein]		 CTD PMID:31181250 NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333 		JBrowse link
G Shh sonic hedgehog signaling molecule multiple interactions ISO
EXP		 [goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of SHH protein]; goralatide inhibits the reaction [AGT protein results in increased expression of SHH protein]
[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of SHH protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of SHH protein]		 CTD PMID:31181250 NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170 		JBrowse link
G Smo smoothened, frizzled class receptor multiple interactions EXP
ISO		 [goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of SMO protein]
[goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in increased expression of SMO protein]; goralatide inhibits the reaction [AGT protein results in increased expression of SMO protein]		 CTD PMID:31181250 NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829 		JBrowse link
G Vim vimentin multiple interactions ISO goralatide affects the reaction [ACE protein affects the reaction [Silicon Dioxide results in increased expression of VIM protein]]; goralatide inhibits the reaction [AGT protein results in increased expression of VIM protein]; goralatide inhibits the reaction [Silicon Dioxide results in increased expression of VIM protein] CTD PMID:33007385 NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187 		JBrowse link
HC toxin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gldc glycine decarboxylase increases expression ISO HC toxin results in increased expression of GLDC mRNA CTD PMID:33770205 NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097 		JBrowse link
G Gpr183 G protein-coupled receptor 183 decreases expression ISO HC toxin results in decreased expression of GPR183 mRNA CTD PMID:33770205 NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 increases expression ISO HC toxin results in increased expression of IDI1 mRNA CTD PMID:33770205 NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357 		JBrowse link
G Klhl42 kelch-like family, member 42 decreases expression ISO HC toxin results in decreased expression of KLHL42 mRNA CTD PMID:33770205 NCBI chr 4:179,999,655...180,027,283
Ensembl chr 4:180,004,580...180,027,283 		JBrowse link
G Mepce methylphosphate capping enzyme decreases expression ISO HC toxin results in decreased expression of MEPCE mRNA CTD PMID:33770205 NCBI chr12:18,911,796...18,916,515
Ensembl chr12:18,911,796...18,916,514 		JBrowse link
G Nrros negative regulator of reactive oxygen species decreases expression ISO HC toxin results in decreased expression of NRROS mRNA CTD PMID:33770205 NCBI chr11:68,628,641...68,646,152
Ensembl chr11:68,628,712...68,646,142 		JBrowse link
G Ppil1 peptidylprolyl isomerase like 1 decreases expression ISO HC toxin results in decreased expression of PPIL1 mRNA CTD PMID:33770205 NCBI chr20:7,302,292...7,322,349
Ensembl chr20:7,302,621...7,322,354 		JBrowse link
G Srgap3 SLIT-ROBO Rho GTPase activating protein 3 increases expression ISO HC toxin results in increased expression of SRGAP3 mRNA CTD PMID:33770205 NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:145,840,078...146,070,575 		JBrowse link
G Tmcc2 transmembrane and coiled-coil domain family 2 increases expression ISO HC toxin results in increased expression of TMCC2 mRNA CTD PMID:33770205 NCBI chr13:43,794,029...43,831,716
Ensembl chr13:43,794,029...43,831,716 		JBrowse link
G Tubb2a tubulin, beta 2A class IIa increases expression ISO HC toxin results in increased expression of TUBB2A mRNA CTD PMID:33770205 NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714 		JBrowse link
G Yes1 YES proto-oncogene 1, Src family tyrosine kinase increases expression ISO HC toxin results in increased expression of YES1 mRNA CTD PMID:33770205 NCBI chr 9:113,200,256...113,275,942
Ensembl chr 9:113,200,256...113,299,837 		JBrowse link
N,N'-(hexane-1,6-diyl)bis(1-\{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl\}-L-prolyl-beta-phenyl-L-phenylalaninamide) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Birc2 baculoviral IAP repeat-containing 2 decreases abundance ISO BV6 decreases abundance of BIRC2 protein in colorectal cancer cells RGD PMID:31289894 RGD:152999013 NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 decreases abundance ISO BV6 decreases abundance of BIRC3 protein in colorectal cancer cells RGD PMID:31289894 RGD:152999013 NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19898
    chemical entity 19896
      group 19849
        organic group 18998
          amino-acid residue 11442
            peptide 11442
              oligopeptide 1350
                tetrapeptide 65
                  Ac-Asp-Glu-Val-Asp-H 0
                  Ac-Cha-Arg-Disc-Met-NH2 0
                  Ac-Cha-Arg-MeAla-Haic-NHCH(CH2OH)2 0
                  Ac-Cha-Arg-Tic-Met-NH2 0
                  Ac-Cha-Arg-Tic-Nle-NHCH2CH2Ph 0
                  Ac-Cha-Gpg-Disc-Met-NH2 0
                  Ac-Cha-Gpg-Disc-Nle-NMeBn 0
                  Ac-Cha-Gpg-Tic-Met-NH2 0
                  Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph 0
                  Ac-Cha-Gpg-Tic-Nle-NHCH2Ph 0
                  Ac-Cha-Gpg-Tic-Nle-NMeBn 0
                  Ac-D-Phe-betaAla-L-His-D-Pro-NH2 0
                  Ac-Gln-D-Phe-His-D-Pro 0
                  Ac-Gln-D-Phe-His-D-Pro-NH2 0
                  Ac-Tyr-Val-Ala-Asp-7-amino-4-trifluoromethylcoumarin 0
                  Ac-Tyr-Val-Ala-Asp-chloromethylketone 0
                  AcGly-Ser(O-D-alpha-D-Hep)-Gly-Leu 0
                  AcGly-Ser(O-L-alpha-D-Hep)-Gly-Leu 0
                  Ala-Ala-Asp-Asp 0
                  Ala-Ala-Pro-Pro 0
                  Ala-Asn-Asn-Pro 0
                  Ala-Asn-Asp-Pro 0
                  Ala-Asn-Gln-Ser 0
                  Ala-Gly-Ala-Gly 0
                  Ala-Leu-Ala-Pro 0
                  Ala-Leu-Asp-Asp 0
                  Ala-Leu-Asp-Gly 0
                  Ala-Leu-Leu-Asp 0
                  Ala-Leu-Leu-His 0
                  Ala-Leu-Leu-Ser 0
                  Ala-Leu-Leu-Thr 0
                  Ala-Leu-Thr-Gln 0
                  Ala-Leu-Thr-Pro 0
                  Ala-Leu-Val-Ser 0
                  Ala-Met-Asp-Tyr 0
                  Ala-Met-Gln-Gln 0
                  Ala-Met-Ser-Arg 0
                  Ala-Phe-Thr-Ser 0
                  Ala-Phe-Trp-Asn 0
                  Ala-Thr-Ala-Pro 0
                  Ala-Trp-Asn-Asp 0
                  Ala-Val-Asp-His 0
                  Ala-Val-Asp-Pro 0
                  Ala-Val-Asp-Ser 0
                  Ala-Val-Asp-Tyr 0
                  Ala-Val-Pro-Pro 0
                  Arg-Asn-Gln-Arg 0
                  Arg-Asn-Gly-Ser 0
                  Arg-Asp-Gln-Ser 0
                  Arg-Cys-Ser-Arg 0
                  Arg-Lys-Cys-Gly 0
                  Arg-Phe-Phe-Cys 0
                  Arg-Thr-Cys-Cys 0
                  Arg-Thr-Thr-Asp 0
                  Arg-Trp-Ser-Tyr 0
                  Asn-Asn-Pro-Ser 0
                  Asn-Cys-Gln-His 0
                  Asn-Gly-Pro-His 0
                  Asn-Leu-Asp-Asp 0
                  Asn-Leu-Leu-Ser 0
                  Asn-Leu-Phe-Asp 0
                  Asn-Lys-His-His 0
                  Asn-Met-Gln-Pro 0
                  Asn-Met-Thr-Thr 0
                  Asn-Met-Trp-Asn 0
                  Asn-Trp-Asp-Ser 0
                  Asn-Trp-Cys-His 0
                  Asp-Leu-Asp-Gln 0
                  Asp-Leu-Leu-Gln 0
                  Asp-Leu-Leu-Ser 0
                  Asp-Leu-Phe-Val 0
                  Asp-Leu-Thr-Asp 0
                  Asp-Leu-Thr-Ser 0
                  Asp-Leu-Val-Ser 0
                  Asp-Met-Met-Cys 0
                  Asp-Met-Thr-Pro 0
                  Asp-Phe-Asp-Gln 0
                  Asp-Phe-Val-Tyr 0
                  Asp-Phe-Val-Val 0
                  Asp-Pro-Ser-Ser 0
                  Asp-Trp-Trp-Val 0
                  Asp-Val-Gly-Pro 0
                  Asp-Val-Pro-Pro 0
                  Asp-Val-Val-Val 0
                  Boc-DON-Gln-Ile-Val-OMe 0
                  Cys-Cys-His-His 0
                  Cys-Gln-Pro-Tyr 0
                  Cys-Met-Met-Met 0
                  Cys-Met-Phe-His 0
                  Cys-Met-Thr-Tyr 0
                  Cys-Phe-Phe-Gly 0
                  Gln-Leu-Leu-Pro 0
                  Gln-Phe-Trp-Tyr 0
                  Glu-Arg-Gly-Met 0
                  Glu-Asp-Gln-Gln 0
                  Glu-Gln-Gln-Tyr 0
                  Glu-Glu-Gln-Trp 0
                  Glu-Leu-Phe-Ala 0
                  Glu-Lys-Trp-Ala 0
                  Glu-Met-Trp-Asp 0
                  Glu-Phe-Cys-Cys 0
                  Glu-Phe-Gln-Gln 0
                  Glu-Thr-Thr-Tyr 0
                  Glu-Trp-Asp-Arg 0
                  Gly-Ser-Gly-Leu + 0
                  HC toxin 11
                  Ile-Leu-Trp-Trp 0
                  Ile-Leu-Val-Tyr 0
                  L-Ala-gamma-D-Glu-meso-Dap-D-Ala 0
                  L-Phe-Gly-L-Leu-L-Met-NH2 0
                  L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanine 0
                  Leu-Asp-Tyr-Arg 0
                  Leu-Ser-Ser-Tyr 0
                  Lys-Met-Met-Met 0
                  Lys-Thr-Pro-Pro 0
                  Lys-Thr-Trp-Tyr 0
                  Met-Glu-Ile-Arg 0
                  N(6)-[N(6)-(N(6)-\{6-[(5-nitro-2-furoyl)amino]hexanoyl\}lysyl)lysyl]lysyl-N(6)-[4-(indol-3-yl)butanoyl]lysinamide 0
                  N-(18-amino-18-oxo-3,6,9,12,15-pentaoxaoctadec-1-yl)-N(2)-\{3-[2-(2-\{[(1-\{[1-(\{1-[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]piperidin-4-yl\}carbonyl)piperidin-4-yl]carbonyl\}piperidin-4-yl)carbonyl]amino\}ethoxy)ethoxy]propanoyl\}-N(6)-(5-nitro-2-furoyl)lysinamide 0
                  N-(\{4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl\}carbonyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-gamma-glutamylglutamic acid 0
                  NBD-N(Me)-DKK(Biotin)betaA-OH 0
                  Pro-Trp-Val-Gly 0
                  Pro-Val-Gly-Pro 0
                  Pro-Val-Val-Pro 0
                  Ser-Asp-Lys-Pro + 16
                  Z-DEVD-FMK 0
                  amastatin 0
                  carfilzomib 34
                  coelichelin 0
                  decanoyl-L-Arg-L-Val-L-Lys-L-Arg-chloromethylketone 0
                  dolastatin 10 0
                  glutamyl-glutathione + 2
                  goralatide 16
                  methyl 1-\{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl\}-L-prolyl-beta-phenyl-L-phenylalaninate + 2
                  soblidotin 0
                  succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin 0
                  tetragastrin 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19898
    subatomic particle 19896
      composite particle 19896
        hadron 19896
          baryon 19896
            nucleon 19896
              atomic nucleus 19896
                atom 19896
                  main group element atom 19835
                    p-block element atom 19835
                      carbon group element atom 19774
                        carbon atom 19771
                          organic molecular entity 19771
                            heteroorganic entity 19528
                              organochalcogen compound 19290
                                organooxygen compound 19206
                                  carbon oxoacid 18675
                                    carboxylic acid 18672
                                      carboacyl group 17712
                                        univalent carboacyl group 17712
                                          carbamoyl group 17563
                                            carboxamide 17563
                                              peptide 11442
                                                oligopeptide 1350
                                                  tetrapeptide 65
                                                    Ac-Asp-Glu-Val-Asp-H 0
                                                    Ac-Cha-Arg-Disc-Met-NH2 0
                                                    Ac-Cha-Arg-MeAla-Haic-NHCH(CH2OH)2 0
                                                    Ac-Cha-Arg-Tic-Met-NH2 0
                                                    Ac-Cha-Arg-Tic-Nle-NHCH2CH2Ph 0
                                                    Ac-Cha-Gpg-Disc-Met-NH2 0
                                                    Ac-Cha-Gpg-Disc-Nle-NMeBn 0
                                                    Ac-Cha-Gpg-Tic-Met-NH2 0
                                                    Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph 0
                                                    Ac-Cha-Gpg-Tic-Nle-NHCH2Ph 0
                                                    Ac-Cha-Gpg-Tic-Nle-NMeBn 0
                                                    Ac-D-Phe-betaAla-L-His-D-Pro-NH2 0
                                                    Ac-Gln-D-Phe-His-D-Pro 0
                                                    Ac-Gln-D-Phe-His-D-Pro-NH2 0
                                                    Ac-Tyr-Val-Ala-Asp-7-amino-4-trifluoromethylcoumarin 0
                                                    Ac-Tyr-Val-Ala-Asp-chloromethylketone 0
                                                    AcGly-Ser(O-D-alpha-D-Hep)-Gly-Leu 0
                                                    AcGly-Ser(O-L-alpha-D-Hep)-Gly-Leu 0
                                                    Ala-Ala-Asp-Asp 0
                                                    Ala-Ala-Pro-Pro 0
                                                    Ala-Asn-Asn-Pro 0
                                                    Ala-Asn-Asp-Pro 0
                                                    Ala-Asn-Gln-Ser 0
                                                    Ala-Gly-Ala-Gly 0
                                                    Ala-Leu-Ala-Pro 0
                                                    Ala-Leu-Asp-Asp 0
                                                    Ala-Leu-Asp-Gly 0
                                                    Ala-Leu-Leu-Asp 0
                                                    Ala-Leu-Leu-His 0
                                                    Ala-Leu-Leu-Ser 0
                                                    Ala-Leu-Leu-Thr 0
                                                    Ala-Leu-Thr-Gln 0
                                                    Ala-Leu-Thr-Pro 0
                                                    Ala-Leu-Val-Ser 0
                                                    Ala-Met-Asp-Tyr 0
                                                    Ala-Met-Gln-Gln 0
                                                    Ala-Met-Ser-Arg 0
                                                    Ala-Phe-Thr-Ser 0
                                                    Ala-Phe-Trp-Asn 0
                                                    Ala-Thr-Ala-Pro 0
                                                    Ala-Trp-Asn-Asp 0
                                                    Ala-Val-Asp-His 0
                                                    Ala-Val-Asp-Pro 0
                                                    Ala-Val-Asp-Ser 0
                                                    Ala-Val-Asp-Tyr 0
                                                    Ala-Val-Pro-Pro 0
                                                    Arg-Asn-Gln-Arg 0
                                                    Arg-Asn-Gly-Ser 0
                                                    Arg-Asp-Gln-Ser 0
                                                    Arg-Cys-Ser-Arg 0
                                                    Arg-Lys-Cys-Gly 0
                                                    Arg-Phe-Phe-Cys 0
                                                    Arg-Thr-Cys-Cys 0
                                                    Arg-Thr-Thr-Asp 0
                                                    Arg-Trp-Ser-Tyr 0
                                                    Asn-Asn-Pro-Ser 0
                                                    Asn-Cys-Gln-His 0
                                                    Asn-Gly-Pro-His 0
                                                    Asn-Leu-Asp-Asp 0
                                                    Asn-Leu-Leu-Ser 0
                                                    Asn-Leu-Phe-Asp 0
                                                    Asn-Lys-His-His 0
                                                    Asn-Met-Gln-Pro 0
                                                    Asn-Met-Thr-Thr 0
                                                    Asn-Met-Trp-Asn 0
                                                    Asn-Trp-Asp-Ser 0
                                                    Asn-Trp-Cys-His 0
                                                    Asp-Leu-Asp-Gln 0
                                                    Asp-Leu-Leu-Gln 0
                                                    Asp-Leu-Leu-Ser 0
                                                    Asp-Leu-Phe-Val 0
                                                    Asp-Leu-Thr-Asp 0
                                                    Asp-Leu-Thr-Ser 0
                                                    Asp-Leu-Val-Ser 0
                                                    Asp-Met-Met-Cys 0
                                                    Asp-Met-Thr-Pro 0
                                                    Asp-Phe-Asp-Gln 0
                                                    Asp-Phe-Val-Tyr 0
                                                    Asp-Phe-Val-Val 0
                                                    Asp-Pro-Ser-Ser 0
                                                    Asp-Trp-Trp-Val 0
                                                    Asp-Val-Gly-Pro 0
                                                    Asp-Val-Pro-Pro 0
                                                    Asp-Val-Val-Val 0
                                                    Boc-DON-Gln-Ile-Val-OMe 0
                                                    Cys-Cys-His-His 0
                                                    Cys-Gln-Pro-Tyr 0
                                                    Cys-Met-Met-Met 0
                                                    Cys-Met-Phe-His 0
                                                    Cys-Met-Thr-Tyr 0
                                                    Cys-Phe-Phe-Gly 0
                                                    Gln-Leu-Leu-Pro 0
                                                    Gln-Phe-Trp-Tyr 0
                                                    Glu-Arg-Gly-Met 0
                                                    Glu-Asp-Gln-Gln 0
                                                    Glu-Gln-Gln-Tyr 0
                                                    Glu-Glu-Gln-Trp 0
                                                    Glu-Leu-Phe-Ala 0
                                                    Glu-Lys-Trp-Ala 0
                                                    Glu-Met-Trp-Asp 0
                                                    Glu-Phe-Cys-Cys 0
                                                    Glu-Phe-Gln-Gln 0
                                                    Glu-Thr-Thr-Tyr 0
                                                    Glu-Trp-Asp-Arg 0
                                                    Gly-Ser-Gly-Leu + 0
                                                    HC toxin 11
                                                    Ile-Leu-Trp-Trp 0
                                                    Ile-Leu-Val-Tyr 0
                                                    L-Ala-gamma-D-Glu-meso-Dap-D-Ala 0
                                                    L-Phe-Gly-L-Leu-L-Met-NH2 0
                                                    L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanine 0
                                                    Leu-Asp-Tyr-Arg 0
                                                    Leu-Ser-Ser-Tyr 0
                                                    Lys-Met-Met-Met 0
                                                    Lys-Thr-Pro-Pro 0
                                                    Lys-Thr-Trp-Tyr 0
                                                    Met-Glu-Ile-Arg 0
                                                    N(6)-[N(6)-(N(6)-\{6-[(5-nitro-2-furoyl)amino]hexanoyl\}lysyl)lysyl]lysyl-N(6)-[4-(indol-3-yl)butanoyl]lysinamide 0
                                                    N-(18-amino-18-oxo-3,6,9,12,15-pentaoxaoctadec-1-yl)-N(2)-\{3-[2-(2-\{[(1-\{[1-(\{1-[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]piperidin-4-yl\}carbonyl)piperidin-4-yl]carbonyl\}piperidin-4-yl)carbonyl]amino\}ethoxy)ethoxy]propanoyl\}-N(6)-(5-nitro-2-furoyl)lysinamide 0
                                                    N-(\{4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl\}carbonyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-gamma-glutamylglutamic acid 0
                                                    NBD-N(Me)-DKK(Biotin)betaA-OH 0
                                                    Pro-Trp-Val-Gly 0
                                                    Pro-Val-Gly-Pro 0
                                                    Pro-Val-Val-Pro 0
                                                    Ser-Asp-Lys-Pro + 16
                                                    Z-DEVD-FMK 0
                                                    amastatin 0
                                                    carfilzomib 34
                                                    coelichelin 0
                                                    decanoyl-L-Arg-L-Val-L-Lys-L-Arg-chloromethylketone 0
                                                    dolastatin 10 0
                                                    glutamyl-glutathione + 2
                                                    goralatide 16
                                                    methyl 1-\{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl\}-L-prolyl-beta-phenyl-L-phenylalaninate + 2
                                                    soblidotin 0
                                                    succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin 0
                                                    tetragastrin 0
paths to the root